Recurrent Ovarian Carcinoma Recruiting Phase 3 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03598270Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)Treatment
NCT03690739Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerPrevention